Joseph A. M. Truluck
2021
In 2021, Joseph A. M. Truluck earned a total compensation of $624.5K as Chief Financial Officer at ADIAL PHARMACEUTICALS, a 38% increase compared to previous year.
Compensation breakdown
Bonus | $45,500 |
---|---|
Option Awards | $316,435 |
Salary | $248,750 |
Other | $13,839 |
Total | $624,524 |
Truluck received $316.4K in option awards, accounting for 51% of the total pay in 2021.
Truluck also received $45.5K in bonus, $248.8K in salary and $13.8K in other compensation.
Rankings
In 2021, Joseph A. M. Truluck's compensation ranked 10,210th out of 12,412 executives tracked by ExecPay. In other words, Truluck earned more than 17.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,210 | 18th |
Manufacturing | 4,513 | 18th |
Chemicals And Allied Products | 2,020 | 15th |
Drugs | 1,791 | 15th |
Pharmaceutical Preparations | 1,330 | 14th |
Truluck's colleagues
We found two more compensation records of executives who worked with Joseph A. M. Truluck at ADIAL PHARMACEUTICALS in 2021.
News
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2023 pay falls 21% to $802K
September 27, 2024
ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2022 pay jumps 118% to $1M
September 29, 2023
ADIAL PHARMACEUTICALS CEO William Stilley's 2021 pay rises 8% to $1.2M
September 1, 2022
ADIAL PHARMACEUTICALS CEO William Stilley's 2019 pay jumps 95% to $2.4M
July 20, 2020
ADIAL PHARMACEUTICALS CEO William Stilley's 2018 pay jumps 232% to $1.2M
July 8, 2019